Source: Eli Lilly press release, May 21, 2026
Trials with liraglutide 1.8 mg have shown weight loss up to 3.6% (3.3 kg) at 26 weeks and 4.7% (5.0 kg) at 56 weeks in subjects with T2D (171173), while trials with liraglutide 3.0 mg have shown weight loss of between 7.9% (8.9 kg) and 8.2% (7.3 kg) at 56 weeks in subjects with obesity (173175)
Following his orthopedic surgery residency at the University of Kentucky, he completed his sports medicine fellowship at the University of Pittsburgh Medical Center (UPMC), where he trained under the late Dr
SCFAs including acetate, butyrate, and propionate have published research supporting their role in stimulating satiety hormones from intestinal L-cells
P values reflect within-group comparisons using the paired t test
Enzymatic Degradation: Pancreatic enzymes degrade any peptides that reach the small intestine